Latinx Teen Depression Treatment Study
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04819295 |
|
Recruitment Status :
Recruiting
First Posted : March 26, 2021
Last Update Posted : September 16, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease |
|---|
| Depression |
| Study Type : | Observational |
| Estimated Enrollment : | 70 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Barriers, Facilitators, and Preferences Regarding Depression Treatment From the Perspectives of Latinx Adolescents, Parents, and Healthcare Providers |
| Actual Study Start Date : | April 20, 2021 |
| Estimated Primary Completion Date : | December 31, 2021 |
| Estimated Study Completion Date : | December 31, 2021 |
| Group/Cohort |
|---|
| Latinx Adolescents |
| Parents of Latinx Adolescents |
| Healthproviders |
- Number of preferences for depression treatment generated from focus groups [ Time Frame: Baseline ]
- Number of barriers to depression treatment among Latinx Adolescents from focus groups [ Time Frame: Baseline ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 13 Years to 17 Years (Child) |
| Sexes Eligible for Study: | All |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Aged 13-17
- self-identify as Hispanic/Latinx
- diagnosed with Major Depressive Disorder or Persistent Depressive Disorder/Dysthymia
- referred to psychotherapy or prescribed medication for depression.
Healthcare providers:
- Self-identify as regularly providing clinical care to Latinx adolescents with depression
- be in a role in which they can refer to or provide depression treatment.
Exclusion Criteria:
- Teens will be excluded if they are experiencing intense psychological distress or imminent thoughts of suicide or have any condition in which, in the opinion of the investigator, precludes the study team from obtaining informed assent of the teen
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04819295
| Contact: Norma G Garcia Ortiz | 9196849331 | ngg12@duke.edu |
| United States, North Carolina | |
| DUSON | Recruiting |
| Durham, North Carolina, United States, 27707 | |
| Contact: Allison Stafford, PhD 919-681-0667 | |
| Principal Investigator: | Allison Stafford, Ph.D | Duke University |
| Responsible Party: | Duke University |
| ClinicalTrials.gov Identifier: | NCT04819295 |
| Other Study ID Numbers: |
Pro00107485 |
| First Posted: | March 26, 2021 Key Record Dates |
| Last Update Posted: | September 16, 2021 |
| Last Verified: | March 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Latinx adolescents psychotherapy Focus groups |
|
Depression Depressive Disorder Behavioral Symptoms Mood Disorders Mental Disorders |

